Search Criteria : Switzerland Geneva
15th European International Society for the Study of Xenobiotics (ISSX) & European Association for Clinical Pharmacology and Therapeutics (EACPT) Meeting is organized by International Society for the Study of Xenobiotics (ISSX) and will be held from Jun 07 - 10, 2020 at Centre International de Conferences Geneve, Geneva, Switzerland. Additional details will be posted as soon as they are available.
Sep 20 - 22, 2020 | Geneva, Geneve
AOTrauma Course - Surgical Approaches to the limbs and pelvis is organized by AOTrauma and will be held from Sep 20 - 22, 2020 at Geneva, Switzerland. Additional details will be posted as soon as information is available.
Oct 04 - 07, 2020 | CME 19 | EUR €700 | Geneva, Geneva
88th European Atherosclerosis Society (EAS) Congress is organized by the European Atherosclerosis Society (EAS), Kenes Group. The session is held from Oct 04 - 07, 2020, 2020 at Palexpo, Geneva, Switzerland. Target Audience The 88th European Atherosclerosis Society Congress is the global meeting place for specialists in the field of clinical chemistry, diabetes, endocrinology, primary care as well as clinicians and basic researchers studying atherosclerosis and related vascular diseases. Because of the diverse, clinically focused educational offering, participants are able to tailor the curriculum to meet the needs of international clinicians of all levels of experience Accreditation Statement and Credit Designation European Accreditation Council for Continuing Medical Education (UEMS/EACCME) The 88th European Atherosclerosis Society Congress is accredited by the European Accreditation Council for Continuing Medical Education (EACCME) to provide the following CME activity for medical specialists. The EACCME is an institution of the European Union of Medical Specialists (UEMS): www.uems.net. The 88th European Atherosclerosis Society Congress is designated for a maximum of, or up to 19 European external CME credits. Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity. Topics: ○ Pathogenesis of Atherosclerosis • Endothelial Cell Function and Biology • Smooth Muscle Cell Biology • Macrophages in Lipid Metabolism and Atherosclerosis • Inflammation, Immunity and Infection in Atherosclerosis • Extracellular Matrix and Calcification • Hormones and Atherosclerosis • Vascular Biology of the Arterial Wall: Miscellaneous • Atherosclerosis Regression • Imaging Technology ○ Lipids and Lipoproteins • Lp(a) • TG Rich Lipoproteins Metabolism and Lipases • HDL • Lipoprotein Receptors • Bile Acids • Cholesterol Efflux and Reverse Cholesterol Transport • lipids Beyond Cholesterol and Triglycerides (Lipidomics) • Cellular Lipid Metabolism and Lipid Droplets • Lipid and Lipoprotein Metabolism: Miscellaneous • Modified Lipoproteins ○ Dyslipidemia and Risk Factors • Epidemiology of Cardiovascular Diseases and Risk Factors • Epidemiology of Dyslipidemias • Diabetes, Insulin Sensitivity and Resistance • Adipose Tissue Homeostasis • Inherited Dyslipidemias • Gender and Cardiovascular Risk • Environmental Risk Factors • Novel Risk Factors and Biomarkers • Epidemiology of Socioeconomic and Psychosocial Risk Factors • Coagulation • Gut Microbiome • Gene Editing Technology • Genomics, GWAS and Population Genetics; Mendelian Randomization • Epigenetics and Microrna • Gene-environment Interactions ○ Clinical Vascular Disease • Coagulation and Thrombosis • Endothelial Dysfunction; Clinical Assessment • Nash and Other Ectopic Lipid Diseases • Chronic Kidney Disease and Nephropathies • Diabetes; Macro- and Microangiopathies • Aneurysms and Other Non-atherosclerotic Arteriopathies • Nutrition, Nutraceuticals • Bariatric Surgery • Lipid-lowering Therapies • Anti-thrombotic Therapies • Anti-inflammatory Therapies • Prevention and Treatment of Cardiovascular disease; Miscellaneous • New Lipid Lowering Therapies Educational Objectives After attending this event, participants should be able to: • Address individual needs in compliance with their Continuous Professional Development (CPD) plan. • Summarize novel treatment strategies to atherosclerosis around the world. • Discuss the new therapeutic approaches to atherosclerotic vascular disease. • Exchange ideas and knowledge in the field of atherosclerosis and related cardiovascular conditions across continents, institutions, and individuals. • Review the latest scientific advantages in the field of atherosclerosis and related cardiovascular conditions. • Identify the foundations of Immunometabolism and implications for metabolic health and disease. • Discuss the current research projects within EAS and enhance opportunities for future collaboration between groups of young researchers. • Identify educational resources and networks for the exchange of knowledge and learning about atherosclerosis.
Nov 16 - 18, 2020 | CHF CHF420 | Geneva, Geneva
This conference has been POSTPONED The revised dates will be updated soon after they are confirmed. Actual Dates: Mar 24 - 25, 2020 Revised Dates: Nov 16 - 18, 2020 Geneva Health Forum is organized by University of Geneva (UNIGE) Institute of Global Health (IGH) and will be held from Nov 16 - 18, 2020 at Centre International de Conferences Geneve, Geneva, Switzerland. Who Should Attend?: • Field actors • Academics • Private sectors • Policy-makers Reasons to Participate: • Discover innovative practices in global health • Learn about new global health challenges • Promote your values, activities, solutions and products • Promote your ideas to key global health stakeholders through direct contacts • Expand your network with a large number of researchers and institutions around the world • Initiate collaborations Course Description: Health systems are facing serious dynamic challenges. Resources are increasingly limited in a rapidly changing world, where the nature of health needs are equally changeable. However, technological progress in the digital age and the emergence of new health actors expand our array of potential solutions to these unprecedented challenges. To ensure the effectiveness of health systems, decisions, at all levels, must be based on the best available evidence and active analysis of actual practices. Unfortunately, research or evaluations of these activities are developed according to long processes that are difficult to reconcile with the need for rapid adaptation of practices. Moreover, the lessons learned do not necessarily translate into a change in policy or practice. It is important that health systems are better organised to become learning systems, can study their own practices to learn lessons that will inform their practices and improve their ability to adapt rapidly to the evolution of health needs. To achieve these learning systems, research and care practices need to be better connected. Learning processes must be continuous, and collaborative, multidisciplinary work is essential to success. New communication tools and mass data management also offer opportunities to facilitate such systems, but their use must be carefully considered and closely monitored, ensuring compliance to ethical and legal standards. At the eighth edition of the GHF, we will explore innovations to improve learning and implementation cycles in global health, to best adapt our practices and improve access to health in a changing world. Additional details will be posted as soon as information is available.
Dec 08 - 12, 2020 | Geneva, Geneva
Congress of the French Society of Arthroscopy (SFA) is organized by Francophone Society of Arthroscopy / Societe Francophone d Arthroscopie (SFA) and will be held during Dec 08 - 12, 2020 at CICG Geneva - International Conference Center Geneva, Geneva, Switzerland. Additional details will be posted as soon as they are available.